Big Move For Ensysce Biosciences Inc.

Ensysce Biosciences Inc. (ENSC:NASDAQ) rocketted at $0.54, a gain of 161.7%. On Tue, Oct 22, 2024, ENSC:NASDAQ touched a New 2-Week High of $0.54. The stock got featured on our News Catalysts scanner on Wed, Oct 02, 2024 at 10:22 AM in the 'INVESTOR UPDATE' category. From Tue, Oct 08, 2024, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Tue, Oct 22, 2024 at $0.82 with a volume of 733M+.
About Ensysce Biosciences Inc. (ENSC:NASDAQ)
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs.
Top 10 Gainers:
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 161.65%
- Genprex, Inc. (GNPX:NASDAQ), 137.75%
- ENDRA Life Sciences Inc. (NDRA:NASDAQ), 90.22%
- Allakos Inc. (ALLK:NASDAQ), 57.04%
- Digital Brands Group Inc. (DBGI:NASDAQ), 49.63%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 48.01%
- Armlogi Holding Corp. (BTOC:NASDAQ), 47.7%
- F45 Training Holdings Inc. (FXLV:NYSE), 40.74%
- Phunware, Inc. (PHUN:NASDAQ), 38.41%
- noco-noco Inc. (NCNC:NASDAQ), 37.39%